Cancer chemotherapy during pregnancy - Consortium of cancer in pregnancy evidence

Citation
M. Lishner et G. Koren, Cancer chemotherapy during pregnancy - Consortium of cancer in pregnancy evidence, CAN FAM PHY, 47, 2001, pp. 41-42
Citations number
15
Categorie Soggetti
General & Internal Medicine
Journal title
CANADIAN FAMILY PHYSICIAN
ISSN journal
0008350X → ACNP
Volume
47
Year of publication
2001
Pages
41 - 42
Database
ISI
SICI code
0008-350X(200101)47:<41:CCDP-C>2.0.ZU;2-3
Abstract
QUESTION I have an 8-weeks' pregnant patient who was diagnosed with stage I II Hodgkin's disease last week. The oncologist suggests delaying chemothera py until the second trimester. What are the effects of chemotherapy on a fe tus after the first trimester? Where can I find reliable information on the subject? ANSWER Available data suggest that exposure to chemotherapy during the firs t trimester of pregnancy is associated with increased risk of major malform ations. Exposure during the second and third trimesters does not result in major malformations, but could have nonteratogenic effects, such as low bir th weight. The brain develops throughout pregnancy, and it could be affecte d later in pregnancy.